It is noteworthy that ongoing research has underscored the significant participation of sphingolipids and their associated enzymes in mediating the PI3K/AKT pathway’s influence on the growth of non-small cell lung cancer (NSCLC) cells (Gulhane and Singh, 2022). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.